Gymnaster koraiensis (Nakai) Kitamura (Compositae) is widely distributed in the northern parts of Korea. This indigenous herb is used as a folk medicine for antitussive and antibacterial activities. 1 Previous phytochemical studies on this plant showed the presence of polyacetylenes, and benzofurans. 2, 3, 4 We have recently reported the isolation of sesquiterpenes and flavonoids from this plant. 5 In a continuing study on this source, we have further isolated two new sesquiterpene glucopyranosides (1) (2) , together with ten known compounds (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) by repeated column chromatography of the EtOH extract. Compounds 3-12 were identified as gymnasterkoreayne B (3), 3 gymnasterkoreayne E (4), 3 gymnasterkoreayne F (5), 3 1,9(Z), 16-heptadecatriene-4,6-diyne-3,8-diol (6), 3, 6 apigenin (7), 7 naringenin (8), 8, 9 apigenin-3-O-β-D-glucopyranoside (9), 10 quercetin-3-O-β-D-glucopyranoside (10), 10 isorhamnetin-3-O-β-Dglucopyranoside (11), 12 apigenin-3-O-β-D-glucuronide (12) 7 by comparing the 1 H-NMR, 13 C-NMR, and mass spectral data with the literature data. Compounds 7-12 were isolated from this plant for the first time. The isolated compounds were tested for their cytotoxicity against four human tumor cell lines in vitro using the SRB assay.
Compound 1 was obtained as colorless gum with a molecular formula of C21H36O8 from the [M+Na] + peak at m/z 439.2306 (calcd. for C21H36O8Na : 439.2308) in the positive-ion HRFA-BMS. The IR spectrum indicated that 1 possessed a hydroxyl (3386 cm -1 ) group and a C=C double bond (1650 cm -1 ). In the 13 C-NMR (including DEPT) spectrum, 21 carbon signals appeared, which included four methyl carbons at δC = 21.9, 21.9, 21.8 and 9.3, two methylene carbons at δC = 32.6 and 30.8, three oxygenated methine carbons at δC = 81.3, 79.6 and 76.6, two olefinic carbons at δC = 136.4 and 120.6, three methine carbons at δC = 52.1, 51.9 and 28.9, one quaternary carbon at δ C = 42.4, and six signals assignable to the glucose moiety (δ C = 104.6, 78.4, 77.3, 76.1, 72.1, and 63.4). These data indicated that compound 1 was a eudesmane type sesquiterpene glucopyranoside. 13 Moreover, the above NMR data, except for the glucose part, were similar to 1β,6β-dihydroxy-7-epi-eudesm-3-ene isolated from Pluchea dioscoridis. 13 The differences were the chemical shifts at C-1, C-6, and C-9 : δ C-1 = 79.6, δ C-6 = 76.6 and δC-9 = 81.3 in 1, and δC-1 = 76.6, δC-6 = 68.4 and δC-9 = 35.3 in 1β,6β-dihydroxy-7-epi-eudesm-3-ene, 13 implying that 1 was glycosylated at C-6 and oxygenated at C-9. The coupling constant (J = 7.5 Hz) of the anomeric proton at δH = 4.36 of D-glucose was in the β-form. 14 The glycosidic position was established by HMBC, with a long-range correlation observed between H-1′ (δ H = 4.36, d, J = 7.5 Hz) and C-6 (δ C = 76.6) ( Figure 1 ). Thus, the structure of 1 was 1,6,9-trihydroxy-transeudesm-3-ene-6-O-β-D-glucopyronoside. The configuration of the hydroxyl group at C-1 was β-form based on the J value (δC = 3.69, dd, J = 11.5, 6.3 Hz) 15, 16 and NOESY spectrum ( Figure 1 ). The configurations of hydroxyl groups at C-6 and C-9 were β-and α-forms, respectively, based on the NOESY correlations: the correlation of H-6 with H-5 (not with H-7), and the correlations of H-9 with H-7 and H-14 ( Figure 1 ). The proposed structure of 1 was in accordance with 1 H-1 H COSY, HMQC, HMBC, and NOESY spectra. Therefore, the structure of 1 was 1β,6β,9α-trihydroxy-trans-eudesm-3-ene-6-O-β-Dglucopyranoside.
Compound 2 was obtained as colorless gum with a molecular formula of C21H36O9 from the [M+Na] + peak at m/z 455.2259 (calcd. for C21H36O9Na : 455.2257) in the positive-ion HRFA-BMS. The IR spectrum indicated that 2 possessed a hydroxy (3382 cm -1 ) and a C=C double bond (1658 cm -1 ). The NMR spectra of 2 were similar to those of compound 1, except for an additional oxygenated carbon signal in the established by HMBC ( Figure 2 ). The relative stereochemistry was the same as 1 based on the NMR data (chemical shifts and J values) and reconfirmed by the NOESY spectrum ( Figure 2) . Thus, the structure of compound 2 was 1β,6β,9α,11-tetrahydroxy-trans-eudesm-3-ene-6-O-β-D-glucopyranoside. Cytotoxic activities of the isolated compounds (1-12) were evaluated against A549, SK-OV-3, SK-MEL-2, and HCT15 human tumor cell lines in vitro using the SRB assay. Compounds 7, 9 and 12 showed moderate cytotoxicity against A549, SK-OV-3, SK-MEL-2 and HCT15 cells, with ED50 values of 7: 9.11, 9.26, 5.94, 8.32 ; 9: 12.07, 11.36, 7.53, 13.51 ; 12: 17.92, 15.04, 10.83, 17.40 µM, respectively, but other compounds did not (ED50 > 30 µM).
Experimental Section
General Procedures. All melting points were determined on a Gallenkamp melting point apparatus and are uncorrected.
Optical rotations were measured on a JASCO P-1020 Polarimeter. UV spectra were obtained using a Shimadzu UV-1601 UV/Visible spectrophotometer (Shimadzu Co.). NMR spectra were recorded on a Varian UNITY INOVA 500 NMR and Bruker Avance 500 NMR spectrometer. FAB-MS data were obtained on a JEOL JMS700 mass spectrometer. Preparative HPLC was performed using a Gilson 306 pump, Shodex refractive index detector, and either an Apollo silica 5µ column (250 × 22 mm) or an Econosil ® RP-18 10µ column (250 × 22 mm). Silica gel 60 (Merck, 70 -230 mesh and 230 -400 mesh) was used for column chromatography. TLC was performed with Merck precoated silica gel F254 plates and RP-18 F254s plates. The packing material in the molecular sieve column chromatography was Sephadex LH-20 (Pharmacia Co.). Low pressure liquid chromatography was performed over Merck LiChroprep Lobar Assignments were performed with DEPT, COSY, HMQC, HMBC and NOESY. Measured in CD3OD. koraiensis (5.0 kg) were extracted with 100% EtOH at room temperature and evaporated under reduced pressure to give residue (250 g), which was dissolved in water (800 mL × 3) and solvent partitioned to give hexane (27 g) and BuOH fractions (85 g). The hexane fraction (27 g) was separated over a silica gel column using a gradient solvent system of hexane : EtOAc (5 : 1 -1 : 1) as the eluent to yield seven fractions (H1 -H7). Fraction H5 (1.8 g) was also subjected to silica gel column chromatography (hexane : EtOAc = 5 : 1 -1 : 1) and was purified with a silica gel prep HPLC with hexane : EtOAc (2.5 : 1) to yield compound 3 (75 mg). Fraction H3 (3.0 g) was also subjected to silica gel column chromatography (hexane : EtOAc = 7 : 1 -2 : 1) and was purified with a silica gel prep HPLC with hexane : CHCl3 : EtOAc (9 : 9 : 1) to yield compounds 4 (14 mg), 5 (10 mg) and 6 (5 mg). The BuOH fraction (85 g) was separated over a silica gel column with a solvent system of CHCl3 : MeOH : Water (35 : 10 : 1 -10 : 5 : 1) to give nine fractions (B1 -B9). Fraction B1 (6.0 g) was also subjected to silica gel column chromatography (CHCl3 : MeOH : Water = 35 : 10 : 1) and was purified with a silica gel prep HPLC with CHCl 3 : MeOH (6 : 1) to yield compounds 1 (60 mg) and 2 (70 mg). Fraction B2 (6.8 g) was also subjected to silica gel column chromatography (CHCl3 : MeOH : Water = 35 : 10 : 1) and was purified with a silica gel prep HPLC with CHCl3 : MeOH (12 : 1) to yield compounds 7 (400 mg) and 8 (4 mg). Fraction B3 (600 mg) was also subjected to RP C-18 column chromatography (20% MeCN) and was purified with a silica gel prep HPLC with 50% MeOH to yield compound 9 (6 mg). Fraction B5 (1.2 g) was also subjected to RP C-18 column chromatography (30% MeOH) and was purified with a silica gel prep HPLC with 50% MeOH to yield compound 10 (12 mg). Fraction B6 (1.6 g) was subjected to LH-20 column chromatography (CH 2 Cl 2 : MeOH = 1 : 1) and was purified with a silica gel prep HPLC with 30% MeOH to yield compounds 11 (12 mg ) 
